Tags

Type your tag names separated by a space and hit enter

Facial nerve function after translabyrinthine vestibular schwannoma surgery.
Otolaryngol Head Neck Surg. 2007 May; 136(5):773-7.OH

Abstract

OBJECTIVES

To evaluate the long-term facial function of patients after translabyrinthine vestibular schwannoma [VS] surgery and identify factors that influence these outcomes.

STUDY DESIGN AND SETTING

A retrospective review was performed that included 580 consecutive patients who underwent translabyrinthine craniotomy for removal of VS at a tertiary referral neurotologic practice between February 2000 and July 2004. A total of 512 patients who underwent primary microsurgical treatment of sporadic unilateral VS met inclusion criteria. Patient and tumor characteristics as well as perioperative complications are described. Perioperative and long-term facial function were evaluated in 392 patients who had at least 1-year follow-up.

RESULTS

Complication rates after translabyrinthine craniotomy for VS are low. Patients with smaller tumors have significantly better postoperative facial function than those with larger tumors.

CONCLUSIONS

Excellent long-term facial function can be expected in the majority of patients who undergo microsurgical removal of VS via the translabyrinthine approach. Alternative treatment strategies may need to be developed for the treatment of VS > 3.5 cm in order to maximize postoperative facial function.

Authors+Show Affiliations

House Clinic, Los Angeles, CA 90057, USA. dbrackmann@hei.orgNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

17478214

Citation

Brackmann, Derald E., et al. "Facial Nerve Function After Translabyrinthine Vestibular Schwannoma Surgery." Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery, vol. 136, no. 5, 2007, pp. 773-7.
Brackmann DE, Cullen RD, Fisher LM. Facial nerve function after translabyrinthine vestibular schwannoma surgery. Otolaryngol Head Neck Surg. 2007;136(5):773-7.
Brackmann, D. E., Cullen, R. D., & Fisher, L. M. (2007). Facial nerve function after translabyrinthine vestibular schwannoma surgery. Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery, 136(5), 773-7.
Brackmann DE, Cullen RD, Fisher LM. Facial Nerve Function After Translabyrinthine Vestibular Schwannoma Surgery. Otolaryngol Head Neck Surg. 2007;136(5):773-7. PubMed PMID: 17478214.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Facial nerve function after translabyrinthine vestibular schwannoma surgery. AU - Brackmann,Derald E, AU - Cullen,Robert D, AU - Fisher,Laurel M, PY - 2006/09/01/received PY - 2006/10/11/accepted PY - 2007/5/5/pubmed PY - 2007/6/22/medline PY - 2007/5/5/entrez SP - 773 EP - 7 JF - Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery JO - Otolaryngol Head Neck Surg VL - 136 IS - 5 N2 - OBJECTIVES: To evaluate the long-term facial function of patients after translabyrinthine vestibular schwannoma [VS] surgery and identify factors that influence these outcomes. STUDY DESIGN AND SETTING: A retrospective review was performed that included 580 consecutive patients who underwent translabyrinthine craniotomy for removal of VS at a tertiary referral neurotologic practice between February 2000 and July 2004. A total of 512 patients who underwent primary microsurgical treatment of sporadic unilateral VS met inclusion criteria. Patient and tumor characteristics as well as perioperative complications are described. Perioperative and long-term facial function were evaluated in 392 patients who had at least 1-year follow-up. RESULTS: Complication rates after translabyrinthine craniotomy for VS are low. Patients with smaller tumors have significantly better postoperative facial function than those with larger tumors. CONCLUSIONS: Excellent long-term facial function can be expected in the majority of patients who undergo microsurgical removal of VS via the translabyrinthine approach. Alternative treatment strategies may need to be developed for the treatment of VS > 3.5 cm in order to maximize postoperative facial function. SN - 0194-5998 UR - https://www.unboundmedicine.com/medline/citation/17478214/Facial_nerve_function_after_translabyrinthine_vestibular_schwannoma_surgery_ L2 - https://journals.sagepub.com/doi/10.1016/j.otohns.2006.10.009?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -